Skip to content

**NeuroCue*, a randomized controlled study into the use of an electronic cognitive aid in patients with acquired brain injury*

**NeuroCue*, a randomized controlled study into the use of an electronic cognitive aid in patients with acquired brain injury* - PDA-intervention in patients with acquired brain injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33708
Enrollment
140
Registered
2008-04-25
Start date
2008-09-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive disorders after brain injury/problems with memory and planning after brain damage

Interventions

The experimental group will receive the PDA-training for a period of 16 weeks, the control group will receive *care-as-usual*, defined as calendar training or other types of strategy training to cop

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients with acquired brain injury in either a subacute or a chronic phase • Patients are referred for cognitive rehabilitation • Age between 18 and 75 years • Adequate comprehension of the Dutch language. - Adequate level of competence • Problems in daily life functioning as a consequence of brain damage, some degree of insight into their cognitive deficits and an estimated IQ high enough to benefit from this treatment according to the rehabilitation physician or psychologist.

Exclusion criteria

Exclusion criteria: - Visual difficulties incompatible with PDA use - Serious psychiatric comorbidity - Progressive disorders, such as Alzheimer*s, Parkinson*s disease and other forms of dementia

Design outcomes

Primary

MeasureTime frame
The first primary outcome is effectiveness of the PDA-intervention, measured a.o. as the efficiency on target behaviours measured with an interview. Furthermore, subjective cognitive problems in daily life and social and instrumental activities will be measured with questionnaires Finally, a measure of self-efficacy will be used. The second primary outcome is *usability* of the device used for the intervention. A semistructured interview will be used to ask the users (patients and caregivers) about their experiences with the use of the PDA. In addition, the log file will be evaluated and the percentage of persons still wanting to use the PDA after 8 and 16 weeks is calculated.

Secondary

MeasureTime frame
Although improvement on neuropsychological test performance is not expected, a pre and post intervention assessment of basic cognitive abilities will be performed .A measure for mood, especially depression after brain injury will be used. Subjective well-being and quality of life are recorded. Finally, some aspects of functioning of the caregiver involved will be assessed: mood (depression), caregiver strain and well-being and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)